Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 44

Sort by

Sort Order Select

Journal Articles

Prediction of VOD Using Biomarkers of Endothelial Injury.

Corey Cutler, MD, MPH, J. Aldridge, H. T. Kim, S. Ayanian, G. Bradwin, C. Revta, G. Murga, V. Ho, E. Alyea, J. Koreth, P. Armand, P. G. Richardson, R. J. Soiffer, J. Ritz, J. H. Antin

Blood (2008) 112 (11): 3267.

https://doi.org/10.1182/blood.V112.11.3267.3267

Published: 2008

Journal Articles

TEL/AML-1 dimerizes and is associated with a favorable outcome in childhood acute lymphoblastic leukemia

TW McLean, S Ringold, D Neuberg, K Stegmaier, R Tantravahi, J Ritz, HP Koeffler, S Takeuchi, JW Janssen, T Seriu, CR Bartram, SE Sallan, DG Gilliland, TR Golub

Blood (1996) 88 (11): 4252–4258.

https://doi.org/10.1182/blood.V88.11.4252.4252

Published: 1996

Journal Articles

High-dose therapy and autologous bone marrow transplantation in patients with follicular lymphoma during first remission

AS Freedman, JG Gribben, D Neuberg, P Mauch, RJ Soiffer, KC Anderson, L Pandite, MJ Robertson, M Kroon, J Ritz, LM Nadler

Blood (1996) 88 (7): 2780–2786.

https://doi.org/10.1182/blood.V88.7.2780.bloodjournal8872780

Published: 1996

Journal Articles

Eradication of polymerase chain reaction-detectable chronic lymphocytic leukemia cells is associated with improved outcome after bone marrow transplantation

D Provan, L Bartlett-Pandite, C Zwicky, D Neuberg, A Maddocks, P Corradini, R Soiffer, J Ritz, LM Nadler, JG Gribben

Blood (1996) 88 (6): 2228–2235.

https://doi.org/10.1182/blood.V88.6.2228.bloodjournal8862228

Published: 1996

Journal Articles

Defective activation of mitogen-activated protein kinase after allogeneic bone marrow transplantation

C Pignata, JS Sanghera, RJ Soiffer, S Chartier, M Eder, SL Pelech, J Ritz

Blood (1996) 88 (6): 2334–2341.

https://doi.org/10.1182/blood.V88.6.2334.bloodjournal8862334

Published: 1996

Journal Articles

Transcript synthesis and surface expression of the interleukin-2 receptor (alpha-, beta-, and gamma-chain) by normal and malignant myeloid cells

RR Schumann, T Nakarai, HJ Gruss, MA Brach, U von Arnim, C Kirschning, L Karawajew, WD Ludwig, JC Renauld, J Ritz, F Herrmann

Blood (1996) 87 (6): 2419–2427.

https://doi.org/10.1182/blood.V87.6.2419.bloodjournal8762419

Published: 1996

Journal Articles

Differential CD26-mediated activation of the CD3 and CD2 pathways after CD6-depleted allogeneic bone marrow transplantation

J Kameoka, T Sato, Y Torimoto, K Sugita, RJ Soiffer, SF Schlossman, J Ritz, C Morimoto

Blood (1995) 85 (4): 1132–1137.

https://doi.org/10.1182/blood.V85.4.1132.bloodjournal8541132

Published: 1995

Journal Articles

Recombinant interleukin-2 infusions and decreased IgG2 subclass concentrations [see comments]

RJ Soiffer, C Murray, J Ritz, N Phillips, D Jacobsohn, S Chartier, DM Ambrosino

Blood (1995) 85 (4): 925–928.

https://doi.org/10.1182/blood.V85.4.925.bloodjournal854925

Published: 1995

Journal Articles

Persistence of myeloid progenitor cells expressing BCR-ABL mRNA after allogeneic bone marrow transplantation for chronic myelogenous leukemia

G Pichert, EP Alyea, RJ Soiffer, DC Roy, J Ritz

Blood (1994) 84 (7): 2109–2114.

https://doi.org/10.1182/blood.V84.7.2109.2109

Published: 1994

Journal Articles

Effect of low-dose interleukin-2 on disease relapse after T-cell- depleted allogeneic bone marrow transplantation

RJ Soiffer, C Murray, R Gonin, J Ritz

Blood (1994) 84 (3): 964–971.

https://doi.org/10.1182/blood.V84.3.964.964

Published: 1994

Journal Articles

CD antigens 1993

SF Schlossman, L Boumsell, W Gilks, JM Harlan, T Kishimoto, C Morimoto, J Ritz, S Shaw, RL Silverstein, TA Springer

Blood (1994) 83 (4): 879–880.

https://doi.org/10.1182/blood.V83.4.879.879

Published: 1994

Journal Articles

Interleukin-12 induces tyrosine phosphorylation and activation of 44-kD mitogen-activated protein kinase in human T cells

C Pignata, JS Sanghera, L Cossette, SL Pelech, J Ritz

Blood (1994) 83 (1): 184–190.

https://doi.org/10.1182/blood.V83.1.184.184

Published: 1994

Journal Articles

Interleukin-12 augments cytolytic activity of peripheral blood lymphocytes from patients with hematologic and solid malignancies

RJ Soiffer, MJ Robertson, C Murray, K Cochran, J Ritz

Blood (1993) 82 (9): 2790–2796.

https://doi.org/10.1182/blood.V82.9.2790.2790

Published: 1993

Journal Articles

Autologous bone marrow transplantation after a long first remission for children with recurrent acute lymphoblastic leukemia

AL Billett, E Kornmehl, NJ Tarbell, HJ Weinstein, RD Gelber, J Ritz, SE Sallan

Blood (1993) 81 (6): 1651–1657.

https://doi.org/10.1182/blood.V81.6.1651.1651

Published: 1993

Journal Articles

Disruption of the SCL locus in T-lymphoid malignancies correlates with commitment to the T-cell receptor alpha beta lineage

EA Macintyre, L Smit, J Ritz, IR Kirsch, JL Strominger

Blood (1992) 80 (6): 1511–1520.

https://doi.org/10.1182/blood.V80.6.1511.1511

Published: 1992

Journal Articles

Serotherapy of B-cell neoplasms with anti-B4-blocked ricin: a phase I trial of daily bolus infusion

ML Grossbard, AS Freedman, J Ritz, F Coral, VS Goldmacher, L Eliseo, N Spector, K Dear, JM Lambert, WA Blattler

Blood (1992) 79 (3): 576–585.

https://doi.org/10.1182/blood.V79.3.576.576

Published: 1992

Journal Articles

Changing antigen receptor gene rearrangements in a case of early pre-B cell leukemia: evidence for a tumor progenitor cell with stem cell features and implications for monitoring residual disease

B Tycko, J Ritz, S Sallan, J Sklar

Blood (1992) 79 (2): 481–488.

https://doi.org/10.1182/blood.V79.2.481.481

Published: 1992

Journal Articles

Clinical and immunologic effects of prolonged infusion of low-dose recombinant interleukin-2 after autologous and T-cell-depleted allogeneic bone marrow transplantation

RJ Soiffer, C Murray, K Cochran, C Cameron, E Wang, PW Schow, JF Daley, J Ritz

Blood (1992) 79 (2): 517–526.

https://doi.org/10.1182/blood.V79.2.517.517

Published: 1992

Journal Articles

Clinical significance of bcr-abl gene rearrangement detected by polymerase chain reaction after allogeneic bone marrow transplantation in chronic myelogenous leukemia

R Delage, RJ Soiffer, K Dear, J Ritz

Blood (1991) 78 (10): 2759–2767.

https://doi.org/10.1182/blood.V78.10.2759.2759

Published: 1991

Journal Articles

Anti-MY9-blocked-ricin: an immunotoxin for selective targeting of acute myeloid leukemia cells

DC Roy, JD Griffin, M Belvin, WA Blattler, JM Lambert, J Ritz

Blood (1991) 77 (11): 2404–2412.

https://doi.org/10.1182/blood.V77.11.2404.2404

Published: 1991

NARROW

Prediction of VOD Using Biomarkers of Endothelial Injury.

TEL/AML-1 dimerizes and is associated with a favorable outcome in childhood acute lymphoblastic leukemia

High-dose therapy and autologous bone marrow transplantation in patients with follicular lymphoma during first remission

Eradication of polymerase chain reaction-detectable chronic lymphocytic leukemia cells is associated with improved outcome after bone marrow transplantation

Defective activation of mitogen-activated protein kinase after allogeneic bone marrow transplantation

Transcript synthesis and surface expression of the interleukin-2 receptor (alpha-, beta-, and gamma-chain) by normal and malignant myeloid cells

Differential CD26-mediated activation of the CD3 and CD2 pathways after CD6-depleted allogeneic bone marrow transplantation

Recombinant interleukin-2 infusions and decreased IgG2 subclass concentrations [see comments]

Persistence of myeloid progenitor cells expressing BCR-ABL mRNA after allogeneic bone marrow transplantation for chronic myelogenous leukemia

Effect of low-dose interleukin-2 on disease relapse after T-cell- depleted allogeneic bone marrow transplantation

CD antigens 1993

Interleukin-12 induces tyrosine phosphorylation and activation of 44-kD mitogen-activated protein kinase in human T cells

Interleukin-12 augments cytolytic activity of peripheral blood lymphocytes from patients with hematologic and solid malignancies

Autologous bone marrow transplantation after a long first remission for children with recurrent acute lymphoblastic leukemia

Disruption of the SCL locus in T-lymphoid malignancies correlates with commitment to the T-cell receptor alpha beta lineage

Serotherapy of B-cell neoplasms with anti-B4-blocked ricin: a phase I trial of daily bolus infusion

Changing antigen receptor gene rearrangements in a case of early pre-B cell leukemia: evidence for a tumor progenitor cell with stem cell features and implications for monitoring residual disease

Clinical and immunologic effects of prolonged infusion of low-dose recombinant interleukin-2 after autologous and T-cell-depleted allogeneic bone marrow transplantation

Clinical significance of bcr-abl gene rearrangement detected by polymerase chain reaction after allogeneic bone marrow transplantation in chronic myelogenous leukemia

Anti-MY9-blocked-ricin: an immunotoxin for selective targeting of acute myeloid leukemia cells

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only